The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
The real value is probably in the customer database as this drives the marketing efficiency. The value of this will not be identfied in the balance sheet ( other than potentially part of the goodwill value) and from personal experience administrators don;t really understand the value of these databases. ( I was part of a team that bought the assets from an administrator for less than £100K and got hundreds of thousands of customer details. We built up the company and sold it a few years later for Multi millions.
It certainly says 27th on the LSE list of results ( see share news icon above) but there is nothing on the CARD investor relations calendar - nothing at all for the whole of 2023. It's not a great sign when listed companies can't keep their own website up to date but fingers crossed if/when they do announce their results
Ricardofin , I there there are a couple of points here .... normally I would agree with you but the directors have an obligation not to issues any misleading information. If they had just said the accounts were delayed and gave no further details that would be worrying but the fact that they went out of their way to state that the delay was at the request of the auditors ( and not for any controversial reasons ) and restating the guidance on profits is reassuring. If there was any doubt at all on this they would not have included this in their RNS and if the delay was due to last minute disagreements with the auditors they would have just left the statement vague. But they didn't so I'm fairly relaxed - usual caveats regarding this being my opinion only etc...
Ricardofin .... today's RNS says it has been delayed and although it came out after trading you wonder whether the delay has caused the dip. The good news is that the RNS restated the trading update that results will be good so I'm not expecting anything bad ( famous last words )
For my two pennies worth. I must admit at being a bit unsettled by the BoD's acceptance of the offer as it seems to be so undervalued that it is almost as if they know something that we don't . That said I have placed 52,500 votes against the offer as I believe it undervalues the medium-long term prospects of the company. Obviously I would be delighted with a counter offer but in the absence of this I accept I have voted for an almost certain short term SP drop but this comes alongside the continued receipt of fairly healthy dividends, a derisked business model and continued potential in the London market. Time will tell.....
Looks like 10 years of patience has finally paid off !!!!!
I think the most important number to consider here is the positive cashflow from operations ( �99 mill last year and �92 million the year before ). This is not a company paying large dividends out of increased debt and I think this is the reason there is limited shorting - definitely not a Carillion. The company seems to have a distinct operational advantage in terms of the ability to make their products cheaper than the competition. Short of a sudden reduction in demand for all cards the company should therefore be sound. The reduced share price seems to be due to pressure on margins which is a legitimate concern but the operational advantage they have at least gives them some tools to utilise. They also have the potential to increase their online business which seems very low but with potential to grow sharply. All in all whilst disappointed the current SP I believe there are reasons to hold. DYOR of course
B'fish - I share your frustration but when you talk about Polo selling GCM shares are you referring to the recent holdings RNS on the GCM website ? I read that as being the consequence of the convertible loan shares being issued end of June with Polo holding the same number of shares but this meaning a lower % of GCM's now enlarged total number of shares. Willing to be corrected if I have misinterpreted.
Not forgetting the reasonable director buy a couple of weeks ago
Seems a very good update - lower vacancy levels must drive margins and they seem very confident of ongoing shortage of supply versus demand. Also the currency play with European portfolio looks positive so I have topped up again. Current price seems a pretty good base and the dividend is pretty good.
I agree and after rereading the latest trading statement took the plunge to buy some more. I didn't get the very bottom but 57.25p has to be a good price given the positives you have mentioned, It's worth rereading the last trading statement as it does remind you of all the potential upsides here.
I would love it to be true but it does seem odd that the website it has been announced on is brand new with only the one article on it and that there has been no RNS. I'm a bit sceptical !
I agree and don't really understand why this share is now valued at less than asset values. Added to your comments I'm attracted by the good dividend yield as well as capital growth potential. Added another 5000 shares this afternoon.
Afraid I didn't get out of MAR in time. They have at least cleaned out the board. Late in filing accounts , presumably they need to get a few things sorted so the can provide some sort of clarity at that time. Happy with rest of portfolio if a bit frustrated in short term that SP's seem to lag. Really confident that HSTN will do well for me and always confident in TEF - think somewhere down the line the challenge is going to be when to exit ( expect minimum £6 but could be higher in a few years time)
My whole portfolio is full of shares that I'm very confident in and seem "no brainers". I keep reviewing as my portfolio has inevitably been hit in the last few weeks but in most cases the underlying business seems strong (MAR being the only exception that I can't do anything about) I have topped up recently in BVS , TEF. INL and LVD as well as HSTN. All seem undervalued and I'm happy to be patient. You seem to be invested or at least interested in most of these so hopefully we are on track for a reward somewhere down the line. Difficult to fight the market in the short term but I have 3 years until I can get to my SIPP so I no rush.
Pleased with the sales growth. Just a bit concerned that there are implications that costs have increased ("Consumer markets remain challenging and organic growth has been hard won, requiring significant promotional investment, NPD and fresh layers of infrastructure") whereas the integration of new businesses should have reduced costs. Overall however happy to hold as this does seem to be a well run company and has done well fro me over the years.
Yes - I took the gamble to buy some more yesterday. Didn't get the bottom but still happy given this update. All the public announcements from this company , plus recent significant director buy , are positive. Also the large CAPEX spend recently shows the directors are either very confident or very incompetent. Hopefully the former .
Reread the half year results again and have decided to top up. The Euro/sterling rate has moved in the last six weeks and I have read some reports that suggest this may continue. This will help European portfolio and the UK business still seems strong. Good dividend payer and plenty of cash to continue to make acquisitions. Share Price seems too low and this is a share that I'm pretty confident will give a good if not spectacular return.
Good to see a director backing up positive trading statements with £95K of their own money. There is a real difference of opinion between these actions and the markets view of the stock with large drop over the last 3 months. I have been waiting for a director buy to back up their RNS so have sided with them with a top up. This is either a good opportunity of the market reading the share wrong or the directors having rose tinted spectacles. My view is that such a large director buy shows at least some conviction on their behalf and unless they are idiots they should have a good view of future prospects.
Fair comment and thanks for replying If they really have overpaid on a committed transaction and without finance in place that is not a great position but will have to wait and see how it pans out.